TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Life Sciences
New findings reported from University of Illinois describe advances in life sciences
July 7th, 2009
According to recent research from the United States, "The possibility that V gamma 2V delta 2 T effector cells can confer protection against pulmonary infectious diseases has not been tested. We have recently demonstrated that single-dose (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP) plus IL-2 treatment can induce prolonged accumulation of V gamma 2V delta 2 T effector cells in lungs." "Here, we show that a delayed HMBPP/IL-2 administration after inhalational Yersinia pestis infection induced marked expansion of V gamma 2V delta 2 T cells but failed to control extracellular plague bacterial replication/infection. Surprisingly, despite the absence of infection...
Source: TB & Outbreaks Week (2009-07-07)
|
